{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:27:10Z","timestamp":1790432830196,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1124\/mol.116.104182","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T21:53:57Z","timestamp":1469570037000},"page":"427-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators"],"prefix":"10.1016","volume":"90","author":[{"given":"Alice E.","family":"Berizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Den Hoedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Langmead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.116.104182_bib1","doi-asserted-by":"crossref","first-page":"33701","DOI":"10.1074\/jbc.M114.604967","article-title":"Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor","volume":"289","author":"Abdul-Ridha","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.104182_bib2","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1074\/jbc.M113.539080","article-title":"Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor","volume":"289","author":"Abdul-Ridha","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.104182_bib3","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1016\/j.bmc.2009.08.024","article-title":"3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists","volume":"17","author":"Aurelio","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/mol.116.104182_bib4","doi-asserted-by":"crossref","first-page":"11452","DOI":"10.1073\/pnas.162371899","article-title":"Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia","volume":"99","author":"Basile","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.116.104182_bib5","doi-asserted-by":"crossref","unstructured":"Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141-162.","DOI":"10.1098\/rspb.1983.0093"},{"key":"10.1124\/mol.116.104182_bib6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1124\/mol.110.068882","article-title":"Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia","volume":"79","author":"Bradley","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.116.104182_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1124\/jpet.108.140350","article-title":"Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats","volume":"327","author":"Brady","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.116.104182_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bmcl.2009.11.089","article-title":"Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM","volume":"20","author":"Bridges","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.116.104182_bib9","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1021\/jm900286j","article-title":"Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins","volume":"52","author":"Bridges","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/mol.116.104182_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/(SICI)1098-2299(199702)40:2<158::AID-DDR6>3.0.CO;2-K","article-title":"Xanomeline: a selective muscarinic agonist for the treatment of Alzheimer\u2019s disease","volume":"40","author":"Bymaster","year":"1997","journal-title":"Drug Dev Res"},{"key":"10.1124\/mol.116.104182_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1074\/jbc.M111.314278","article-title":"A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation","volume":"287","author":"Canals","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.104182_bib12","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1073\/pnas.0800567105","article-title":"Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia","volume":"105","author":"Chan","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.116.104182_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0165-6147(98)01240-1","article-title":"Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log","volume":"19","author":"Christopoulos","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.116.104182_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/mol.114.094342","article-title":"Advances in G protein-coupled receptor allostery: from function to structure","volume":"86","author":"Christopoulos","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.116.104182_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.2042-7158.1997.tb06112.x","article-title":"Application of an allosteric ternary complex model to the technique of pharmacological resultant analysis","volume":"49","author":"Christopoulos","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/mol.116.104182_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders","volume":"8","author":"Conn","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.116.104182_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/mol.114.091751","article-title":"Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors","volume":"86","author":"Croy","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.116.104182_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12595","article-title":"Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs","volume":"503","author":"Dror","year":"2013","journal-title":"Nature"},{"key":"10.1124\/mol.116.104182_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jnr.10728","article-title":"Role for M5 muscarinic acetylcholine receptors in cocaine addiction","volume":"74","author":"Fink-Jensen","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1124\/mol.116.104182_bib49","doi-asserted-by":"crossref","unstructured":"Foster DJ, Gentry PR, Lizardi-Ortiz JE, Bridges TM, Wood MR, Niswender CM, Sulzer D, Lindsley CW, Xiang Z, Conn PJ. (2014) J Neurosci 34:3253\u20133262.","DOI":"10.1523\/JNEUROSCI.4896-13.2014"},{"key":"10.1124\/mol.116.104182_bib21","doi-asserted-by":"crossref","first-page":"9351","DOI":"10.1021\/jm4013246","article-title":"Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)","volume":"56","author":"Gentry","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/mol.116.104182_bib22","doi-asserted-by":"crossref","unstructured":"Gentry PR, Kokubo M, Bridges TM, Noetzel MJ, Cho HP, Lamsal A, Smith E, Chase P, Hodder PS, Niswender CM et al. (2014). Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380). J Med Chem 57:7804\u20137810.","DOI":"10.1021\/jm500995y"},{"key":"10.1124\/mol.116.104182_bib23","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1074\/jbc.M109.094011","article-title":"Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias","volume":"285","author":"Gregory","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.104182_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/157015907781695946","article-title":"Allosteric modulation of muscarinic acetylcholine receptors","volume":"5","author":"Gregory","year":"2007","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/mol.116.104182_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1124\/mol.105.014043","volume":"68","author":"Huang","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.116.104182_bib26","doi-asserted-by":"crossref","first-page":"23817","DOI":"10.1074\/jbc.M114.582874","article-title":"Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor","volume":"289","author":"Keov","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.104182_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.116.104182_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12735","article-title":"Activation and allosteric modulation of a muscarinic acetylcholine receptor","volume":"504","author":"Kruse","year":"2013","journal-title":"Nature"},{"key":"10.1124\/mol.116.104182_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets","volume":"117","author":"Langmead","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.116.104182_bib30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/npp.2009.194","article-title":"Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties","volume":"35","author":"Leach","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.116.104182_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2007.06.004","article-title":"Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology","volume":"28","author":"Leach","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.116.104182_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1476-5381.1993.tb13799.x","article-title":"Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model-fitting approach","volume":"110","author":"Leff","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.116.104182_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0026-895X(24)12169-4","article-title":"CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding","volume":"55","author":"Litschig","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.116.104182_bib34","doi-asserted-by":"crossref","first-page":"15950","DOI":"10.1073\/pnas.0900903106","article-title":"Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation","volume":"106","author":"Ma","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.116.104182_bib35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.bjp.0705159","article-title":"Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP","volume":"138","author":"Mathiesen","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.116.104182_bib36","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.lfs.2004.05.034","article-title":"Functional analysis of muscarinic acetylcholine receptors using knockout mice","volume":"75","author":"Matsui","year":"2004","journal-title":"Life Sci"},{"key":"10.1124\/mol.116.104182_bib37","doi-asserted-by":"crossref","unstructured":"Motulsky H and Christopoulos A (2004) Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting, Oxford University Press, Oxford.","DOI":"10.1093\/oso\/9780195171792.001.0001"},{"key":"10.1124\/mol.116.104182_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(02)02721-X","article-title":"M1 muscarinic receptor signaling in mouse hippocampus and cortex","volume":"944","author":"Porter","year":"2002","journal-title":"Brain Res"},{"key":"10.1124\/mol.116.104182_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0920-9964(99)00138-3","article-title":"Xanomeline, an M(1)\/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice","volume":"42","author":"Shannon","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1124\/mol.116.104182_bib40","doi-asserted-by":"crossref","first-page":"14271","DOI":"10.1523\/JNEUROSCI.3930-09.2009","article-title":"A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning","volume":"29","author":"Shirey","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/mol.116.104182_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nchembio.2007.55","article-title":"An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission","volume":"4","author":"Shirey","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1124\/mol.116.104182_bib42","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1523\/JNEUROSCI.2077-05.2005","article-title":"Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice","volume":"25","author":"Thomsen","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/mol.116.104182_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1124\/mol.111.074872","article-title":"Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects","volume":"81","author":"Valant","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.116.104182_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0304-3940(90)90064-G","article-title":"Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry","volume":"114","author":"Vilar\u00f3","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1124\/mol.116.104182_bib45","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1073\/pnas.87.18.7050","article-title":"Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia","volume":"87","author":"Weiner","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.116.104182_bib46","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.116.104182_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.lfs.2003.09.022","article-title":"Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology","volume":"74","author":"Yamada","year":"2003","journal-title":"Life Sci"},{"key":"10.1124\/mol.116.104182_bib48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0026-895X(25)13594-3","article-title":"Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain","volume":"43","author":"Yasuda","year":"1993","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24005121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24005121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.116.104182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:14:34Z","timestamp":1739942074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24005121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0026895X24005121"],"URL":"https:\/\/doi.org\/10.1124\/mol.116.104182","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.116.104182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}